Evaluating metabolic changes in heart disease by magnetic resonance spectroscopy

Heart and Metabolism

Volumn , Issue 32, 2006, Pages 18-21

  Ten Hove, Michiel ^a,b   Neubauer, Stefan ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

13C magnetic resonance spectroscopy; 1H magnetic resonance spectroscopy; 31P magnetic resonance spectroscopy; Cardiac metabolism

Indexed keywords

2 OXOGLUTARIC ACID; ACETYL COENZYME A; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; FATTY ACID; GLUCOSE; GLUTAMIC ACID; GUANIDINOACETATE METHYLTRANSFERASE; METHYLTRANSFERASE; PHOSPHORUS 31; PYRUVIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; TRICARBOXYLIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONGESTIVE CARDIOMYOPATHY; ENERGY METABOLISM; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE METABOLISM; HEART MUSCLE OXYGEN CONSUMPTION; HEART VENTRICLE HYPERTROPHY; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 33750631549     PISSN: 15660338     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ten Hove M, Lygate CA, Fischer A, et al. Reduced inotropic reserve and increased susceptibility to cardiac ischemia/reperfusion injury in phosphocreatine-deficient guanidinoacetate-N-methyltransferase-knockout mice. Circulation. 2005;111:2477-2485.
2. Neubauer S, Horn M, Naumann A, et al. Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. J Clin Invest. 1995;95:1092-1100.
3. Murakami Y, Zhang Y, Cho YK, et al. Myocardial oxygenation during high work states in hearts with postinfarction remodeling. Circulation. 1999;99:942-948.
4. Tian R, Nascimben L, Kaddurah Daouk R, Ingwall JS. Depletion of energy reserve via the creatine kinase reaction during the evolution of heart failure in cardiomyopathic hamsters. J Mol Cell Cardiol. 1996;28:755-765.
5. Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J. 1991;122:795-801.
6. 31P- magnetic resonance spectroscopy to the understanding of dilated heart muscle disease. Eur Heart J. 1995;16 (suppl O):115-118.
7. Neubauer S, Horn M, Cramer M, et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation. 1997;96:2190-2196.
8. 31P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol. 2002;40:1267-1274.
9. Weiss RG, Gerstenblith G, Bottomley PA. ATP flux through creatine kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci U S A. 2005;102:808-813.
10. Scheuermann-Freestone M, Madsen PL, Manners D, et al. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation. 2003;107:3040-3046.
11. Saupe KW, Spindler M, Hopkins JC, Shen W, Ingwall JS. Kinetic, thermodynamic, and developmental consequences of deleting creatine kinase isoenzymes from the heart. Reaction kinetics of the creatine kinase isoenzymes in the intact heart. J Biol Chem. 2000;275:19742-19746.
12. Wallis J, Lygate CA, Fischer A, et al. Supra-normal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure - insights from creatine transporter over-expression transgenic mice. Circulation. 2005;112:3131-3139.
13. Weiss RG, Chatham JC, Georgakopolous D, et al. An increase in the myocardial PCr/ATP ratio in GLUT4 null mice. FASEB J. 2002;16:613-615.
14. Luptak I, Balschi JA, Xing Y, Leone TC, Kelly DP, Tian R. Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization. Circulation. 2005;112:2339-2346.
15. Spindler M, Saupe KW, Christe ME, et al. Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. J Clin Invest. 1998;101:1775-1783.
16. Carvalho RA, Zhao P, Wiegers CB, Jeffrey FM, Malloy CR, Sherry AD. TCA cycle kinetics in the rat heart by analysis of C isotopomers using indirect H. Am J Physiol Heart Circ Physiol. 2001;281:H1413-H1421.
17. 13C NMR spectroscopy. NMR Biomed. 2002;15:222-234.
18. O'Donnell JM, Zampino M, Alpert NM, Fasano MJ, Geenen DL, Lewandowski ED. Accelerated triacylglycerol turnover kinetics in hearts of diabetic rats include evidence for compartmented lipid storage. Am J Physiol Endocrinol Metab. 2006;290:E448-E455.
19. Flogel U, Laussmann T, Godecke A, et al. Lack of myoglobin causes a switch in cardiac substrate selection. Circ Res. 2005;96:e68-e75.
20. 1H-NMR visibility of creatine in isolated rat hearts. Magn Reson Med. 2000;43:497-502.
21. Nakae I, Mitsunami K, Omura T, et al. Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy. J Am Coll Cardiol. 2003;42:1587-1593.
22. 1H-MRS in the mouse. Magn Reson Med. 2004;52:1029-1035.
23. Flogel U, Merx MW, Godecke A, Decking UK, Schrader J. Myoglobin: a scavenger of bioactive NO. Proc Natl Acad Sci U S A. 2001;98:735-740.
24. Mayr M, Chung YL, Mayr U, et al. Loss of PKC-delta alters cardiac metabolism. Am J Physiol Heart Circ Physiol. 2004;287:H937-H945.
25. Ardenkjaer-Larsen JH, Fridlund B, Gram A, et al. Increase in signal-to-noise ratio of >10 000 times in liquid-state NMR. Proc Natl Acad Sci U S A. 2003;100:10158-10163.